Related Experiment Video
Updated: Jul 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Compromised HOXA5 function can limit p53 expression in human breast tumours
V Raman1, S A Martensen, D Reisman
1Breast Cancer Program, Johns Hopkins Oncology Center, Baltimore, Maryland 21231, USA.
Abstract:
Expression of the p53 gene protects cells against malignant transformation. Whereas control of p53 degradation has been a subject of intense scrutiny, little is known about the factors that regulate p53 synthesis. Here we show that p53 messenger RNA levels are low in a large proportion of breast tumours. Seeking potential regulators of p53 transcription, we found consensus HOX binding sites in the p53 promoterS. Transient transfection of Hox/HOXA5 activated the p53 promoter. Expression of HOXA5 in epithelial cancer cells expressing wild-type p53, but not in isogenic variants lacking the p53 gene, led to apoptotic cell death. Moreover, breast cancer cell lines and patient tumours display a coordinate loss of p53 and HOXA5 mRNA and protein expression. The HOXA5 promoter region was methylated in 16 out of 20 p53-negative breast tumour specimens. We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.
Insights
Loss of p53 gene expression in breast tumors is linked to reduced HOXA5. This suggests HOXA5 deficiency may cause p53 loss, impacting cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 gene is crucial for preventing malignant transformation.
- Regulation of p53 synthesis, unlike its degradation, is poorly understood.
- Reduced p53 messenger RNA (mRNA) levels are observed in many breast tumors.
Purpose of the Study:
- To identify factors regulating p53 transcription.
- To investigate the role of HOX genes in p53 regulation.
- To explore the relationship between HOXA5 and p53 expression in breast cancer.
Main Methods:
- Analysis of p53 promoter for HOX binding sites.
- Transient transfection assays using Hox/HOXA5.
- Assessing apoptosis in cancer cells with varying p53 and HOXA5 expression.
- Quantification of p53 and HOXA5 mRNA and protein in cell lines and patient tumors.
- Methylation analysis of the HOXA5 promoter region.
Main Results:
- Consensus HOX binding sites were identified in the p53 promoter.
- Hox/HOXA5 transfection activated the p53 promoter.
- HOXA5 expression induced apoptosis in p53-positive cancer cells but not in p53-deficient cells.
- Breast cancer cell lines and patient tumors showed coordinated loss of p53 and HOXA5.
- HOXA5 promoter methylation was frequent in p53-negative tumors.
Conclusions:
- Loss of p53 expression in human breast cancer may stem from reduced HOXA5 expression.
- HOXA5 acts as a regulator of p53 transcription.
- Aberrant HOXA5 expression and promoter methylation contribute to p53 deficiency in breast cancer.
More Related Videos
Related Concept Videos
Hedgehog Signaling Pathway
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

